Accelerate Diagnostics Cash Flow - Quarterly (NASDAQ:AXDX)

Add to My Stocks
$28.1 $0.3 (1.06%) AXDX stock closing price May 23, 2017 (Closing)

For analyzing any company like Accelerate Diagnostics from an investment perspective, its important to check the cash flow statement. In simple terms, the cash flow statement measures the cash that has come into the company, and the cash that has gone out during a given period, while the other statements, the income statement and balance sheet, give details about Accelerate Diagnostics profits and Accelerate Diagnostics debt. The cash flow statement is essetial while conducting the Accelerate Diagnostics cash flow analysis and can be used to measure the operating performance of Accelerate Diagnostics compared to various industry peers like ARTC stock and CYNO stock. Accelerate Diagnostics had an inflow of $37.93M from operating activities, $0.27M inflow due to financing activities, and $53.61M gain due to investing activities for 2017-Q1. View details of Accelerate Diagnostics cash flows for latest & last 40 quarters.

show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec. 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4
Accelerate Diagnostics Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow0.63M2.72M2M1.27M0.58M1.98M1.34M0.83M0.37M1.15M
Net Increase (Decrease) in Assets Liabilities-5.14M1.54M1.12M-0.25M-0.39M--0.24M-0.22M-0.09M1.36M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net3.24M8.7M6.5M3.83M1.68M8.38M5.99M4.18M1.65M9.62M
Accelerate Diagnostics Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.23M-2.4M-2.3M-2.08M-1.68M-3.65M-2.59M-2.16M-1.19M-1.93M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments4.28M-47.15M-49.91M-53.15M-32.81M0.98M-0.97M-0.06M1.95M-1.43M
Other Cash Inflow (Outflow) from Investment Activities----------
Accelerate Diagnostics Net Cash from (used by) Invesment Activities
Issuance (Purchase) of Equity Shares2.03M1.72M0.94M0.09M0.02M104.97M0.54M0.32M0.06M45.79M
Issuance (Repayment) of Debt Securities--0.01M-0.01M-0.01M-0.01M-0.14M-0.11M-0.07M-0.03M-0.1M
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities-0.05M0.05M0.17M-0.81M-----
Accelerate Diagnostics Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash0.06M-0.12M-0.01M--0.04M-----
Accelerate Diagnostics Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year120.58M53.56M30.02M12.06M-0.77M0.28M0.86M1.23M1.39M
Cash & Equivalents at Year End9.92M19.24M28.73M37.51M72.03M120.58M25.19M35.23M47.39M53.56M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Cash flow for another ticker

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The Accelerate Diagnostics stock price history and Accelerate Diagnostics stock comparison chart inevitably reflect its cash flow situation.
  • Net Change in Cash and Cash Equivalents: Accelerate Diagnostics cash grew QoQ to $-14.2M, meaning the company is able to meet its expenditure and grow cash which will also eventually reflect in the Accelerate Diagnostics stock price movement.
  • The cash generated from the core business or operations was negative at $-15.47M for Accelerate Diagnostics in the latest quarter. For an internet company, this would include all those activities which are involved in eventually selling advertisement space on its website or any online service.
  • Cash Flow from investment activities: Accelerate Diagnostics generated $53.61M cash due to investment activities. It includes the use of cash outside of normal day to day activities like buying fixed assets, plant and machinery etc.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $2.03M for Accelerate Diagnostics.

Key Financial Ratios For Accelerate Diagnostics Cash Flow

FCF margin